Nektar Therapeutics | NKTR - Trade Debtors


Nektar Therapeutics reported $0 in Trade Debtors for its fiscal quarter ending in September of 2024.





Trade Debtors Change Date
Agios Pharmaceuticals USD 10.58M 5.55M Dec/2025
ALKERMES USD 334.02M 21.08M Dec/2025
Alterity Therapeutics Limited AUD 8.67M 1.59M Jun/2023
Amgen USD 9.57B 1.08B Dec/2025
Baxter International USD 2.01B 231M Dec/2025
BioCryst Pharmaceuticals USD 79.07M 6.61M Dec/2024
Biogen USD 1.85B 234M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Cipla INR 74.61B 19.39B Sep/2025
Dr.Reddys Laboratories INR 104.17B 3.61B Dec/2025
Eisai JPY 249.06B 25B Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Esperion Therapeutics USD 60.36M 5.75M Jun/2024
Exelixis USD 286.92M 24.38M Dec/2025
Gilead Sciences USD 4.91B 182M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Grifols EUR 1.29B 83.03M Sep/2025
Halozyme Therapeutics USD 441.27M 95.24M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
Karyopharm Therapeutics USD 31.78M 6.82M Sep/2024
MacroGenics USD 69.23M 56.7M Sep/2025
Merck USD 12.12B 596M Sep/2025
Nektar Therapeutics USD 0 2.9M Sep/2024
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Novartis USD 8.98B 192M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
Takeda JPY 757.92B 55.68B Dec/2025
Teva Pharmaceutical Industries USD 3.71B 101M Dec/2025
Xencor USD 29.3M 7.49M Dec/2025